Nutcracker Therapeutics

Emeryville, United States

Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.

$167.0M raised

Mar 2022

Series C

Biotechnology Health Care Pharmaceutical Therapeutics

Top Investors

ARCH Venture Partners Bluebird Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Nutcracker Therapeutics

How much funding has Nutcracker Therapeutics raised?

Nutcracker Therapeutics has raised $167.0M in total funding. The most recent round was Series C. The last funding was announced in March 2022.

Who are Nutcracker Therapeutics's investors?

Nutcracker Therapeutics's investors include ARCH Venture Partners, Bluebird Ventures.

Where is Nutcracker Therapeutics headquartered?

Nutcracker Therapeutics is headquartered in Emeryville, United States.

What does Nutcracker Therapeutics do?

Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.

What stage is Nutcracker Therapeutics at?

Nutcracker Therapeutics is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 14, 2022.

MLA

"Nutcracker Therapeutics — Funding & Investors." VCBacked, March 14, 2022, https://www.vcbacked.co/company/nutcracker-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). Nutcracker Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/nutcracker-therapeutics

Wikipedia (cite web)

{{cite web |title=Nutcracker Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nutcracker-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 14, 2022.